ARCHIVES

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

This article is from The Cancer Letter archive.

Vol. 27 No. 22 | June 1, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Warns Of Pill’s Potential Tumor Threat

April 2, 1976

Despite NCI director’s enthusiasm, “We have a long way to go before we beat cancer,” the former NIH director says.

May 20, 2005

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981

In Brief: Chemical Carcinogenesis, Epidemiology Trail Viral Oncology In Budget Growth, Board Notes

November 7, 1980

Recision, 1981 Budget Threats Hangover NCI

March 14, 1980

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999